Live
Lab-DirectCardiovascular Pacing and ICD Leads Price in Northern America - Market Insights - IndexBoxMerck KGaAMerck KGaA Backs Hybrid Cancer Drugs And Greener Lab Consumables - simplywall.stBioPharma DiveArvinas’ ‘Protac’ breast cancer drug cleared by FDAClinical OMICsData-Driven Tool Identifies Individuals at Highest Risk of Obesity-Related DiseaseClinical OMICsMachine Learning Tool Helps Improve Type 1 Diabetes PredictionClinical OMICsPatient-Derived Lab-on-a-Chip Improves Precision Modeling of Pancreatic CancerClinical OMICsCitraconate Enhances Antitumor Activity and Reduces Exhaustion in T CellsEndpoints NewsModerna in talks with FDA over Phase 4 Covid vaccine dataBio-RadBio-Rad Weighs 2026 Outlook As Middle East Headwinds Meet Stilla Hopes - simplywall.stEndpoints NewsFDA approves Pfizer and Arvinas' breast cancer drug despite underwhelming dataModernaModerna’s first quarter 2026 sales well ahead of estimates - The Pharma LetterEndpoints NewsAmgen launches late-stage obesity trial in patients who switch from rival drugs
Endpoints News Mar 17, 2026

CMS innovation center to expand team focused on drug prices

CMS innovation center to expand team focused on drug prices

Original
Body unavailable. Use the original source.